Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LOPERAMIDA COMBIX 2 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LOPERAMIDA COMBIX 2 MG CAPSULAS DURAS EFG

Approved

STANDARD

LOPERAMIDA COMBIX 2 MG CAPSULAS DURAS EFG

Laboratorios Combix S.L.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 14, 2025
Approval ID: bcf90e54ba636dd2
Company: Laboratorios Combix S.L.U.
Type: Standard

Approval Details

Approval Id: bcf90e54ba636dd2
Drug Cima Aemps Name: LOPERAMIDA COMBIX 2 MG CAPSULAS DURAS EFG
Register Number: 90663
Holder Company Name: Laboratorios Combix S.L.U.
Marketing Company Name: Laboratorios Combix S.L.U.
Authorization Date: 2025-10-14
Dosage Form: CÁPSULA DURA
Dose: 2 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: No
Company Name: Laboratorios Combix S.L.U.

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 14, 2025

Approval ID

bcf90e54ba636dd2

Type

Standard

Back to CIMA-AEMPS Approvals